These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 19536347)

  • 1. Vascular and neural dysfunctions in obese Zucker rats: effect of AVE7688.
    Davidson EP; Coppey LJ; Kleinschmidt TL; Oltman CL; Yorek MA
    Exp Diabetes Res; 2009; 2009():912327. PubMed ID: 19536347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of vascular/neural dysfunction in Zucker rats treated with enalapril or rosuvastatin.
    Oltman CL; Davidson EP; Coppey LJ; Kleinschmidt TL; Lund DD; Yorek MA
    Obesity (Silver Spring); 2008 Jan; 16(1):82-9. PubMed ID: 18223617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Zucker diabetic fatty rats with AVE7688 improves vascular and neural dysfunction.
    Oltman CL; Davidson EP; Coppey LJ; Kleinschmidt TL; Yorek MA
    Diabetes Obes Metab; 2009 Mar; 11(3):223-33. PubMed ID: 18564175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of treatment of high fat fed/low dose streptozotocin-diabetic rats with Ilepatril on vascular and neural complications.
    Davidson EP; Coppey LJ; Holmes A; Dake B; Yorek MA
    Eur J Pharmacol; 2011 Oct; 668(3):497-506. PubMed ID: 21816138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of streptozotocin-induced diabetic rats with AVE7688, a vasopeptidase inhibitor: effect on vascular and neural disease.
    Davidson EP; Kleinschmidt TL; Oltman CL; Lund DD; Yorek MA
    Diabetes; 2007 Feb; 56(2):355-62. PubMed ID: 17259379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of inhibition of angiotensin converting enzyme and/or neutral endopeptidase on vascular and neural complications in high fat fed/low dose streptozotocin-diabetic rats.
    Davidson EP; Coppey LJ; Holmes A; Yorek MA
    Eur J Pharmacol; 2012 Feb; 677(1-3):180-7. PubMed ID: 22198047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the effect of inhibition of neutral endopeptidase on vascular and neural complications in streptozotocin-induced diabetic rats.
    Oltman CL; Davidson EP; Coppey LJ; Kleinschmidt TL; Dake B; Yorek MA
    Eur J Pharmacol; 2011 Jan; 650(2-3):556-62. PubMed ID: 21040718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasopeptidase inhibition improves insulin sensitivity and endothelial function in the JCR:LA-cp rat.
    Russell JC; Kelly SE; Schäfer S
    J Cardiovasc Pharmacol; 2004 Aug; 44(2):258-65. PubMed ID: 15243308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasopeptidase inhibitor ilepatril (AVE7688) prevents obesity- and diabetes-induced neuropathy in C57Bl/6J mice.
    Coppey L; Davidson E; Lu B; Gerard C; Yorek M
    Neuropharmacology; 2011; 60(2-3):259-66. PubMed ID: 20849865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular and neural dysfunction in Zucker diabetic fatty rats: a difficult condition to reverse.
    Oltman CL; Davidson EP; Coppey LJ; Kleinschmidt TL; Lund DD; Adebara ET; Yorek MA
    Diabetes Obes Metab; 2008 Jan; 10(1):64-74. PubMed ID: 17970755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasopeptidase inhibition normalizes blood pressure and restores endothelial function in renovascular hypertension.
    Quaschning T; Hocher B; Ruhl S; Kraemer-Guth A; Tilgner J; Wanner C; Galle J
    Kidney Blood Press Res; 2006; 29(6):351-9. PubMed ID: 17139187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in endoneurial blood flow, motor nerve conduction velocity and vascular relaxation of epineurial arterioles of the sciatic nerve in ZDF-obese diabetic rats.
    Coppey LJ; Gellett JS; Davidson EP; Dunlap JA; Yorek MA
    Diabetes Metab Res Rev; 2002; 18(1):49-56. PubMed ID: 11921418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephroprotection in Zucker diabetic fatty rats by vasopeptidase inhibition is partly bradykinin B2 receptor dependent.
    Schäfer S; Schmidts HL; Bleich M; Busch AE; Linz W
    Br J Pharmacol; 2004 Sep; 143(1):27-32. PubMed ID: 15289289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The vasopeptidase inhibitor AVE7688 ameliorates Type 2 diabetic nephropathy.
    Schäfer S; Linz W; Vollert H; Biemer-Daub G; Rütten H; Bleich M; Busch AE
    Diabetologia; 2004 Jan; 47(1):98-103. PubMed ID: 14618238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Treatment of Sprague Dawley Rats with AVE7688, Enalapril, or Candoxatril on Diet-Induced Obesity.
    Davidson EP; Coppey LJ; Dake B; Yorek MA
    J Obes; 2011; 2011():. PubMed ID: 20847891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diet-induced obesity in Sprague-Dawley rats causes microvascular and neural dysfunction.
    Davidson EP; Coppey LJ; Calcutt NA; Oltman CL; Yorek MA
    Diabetes Metab Res Rev; 2010 May; 26(4):306-18. PubMed ID: 20503263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasopeptidase inhibitor restores the balance of vasoactive hormones in progressive nephropathy.
    Benigni A; Zoja C; Zatelli C; Corna D; Longaretti L; Rottoli D; Maggioni P; Todeschini M; Noris M; Remuzzi G
    Kidney Int; 2004 Nov; 66(5):1959-65. PubMed ID: 15496167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasopeptidase inhibition attenuates proteinuria and podocyte injury in Zucker diabetic fatty rats.
    Fredersdorf S; Weil J; Ulucan C; Birner C; Büttner R; Schubert T; Böger CA; Debl K; Muders F; Riegger GA; Luchner A
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Apr; 375(2):95-103. PubMed ID: 17333128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression of coronary and mesenteric vascular dysfunction in Zucker obese and Zucker diabetic fatty rats.
    Oltman CL; Richou LL; Davidson EP; Coppey LJ; Lund DD; Yorek MA
    Am J Physiol Heart Circ Physiol; 2006 Oct; 291(4):H1780-7. PubMed ID: 16714356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of M40403 treatment of diabetic rats on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve.
    Coppey LJ; Gellett JS; Davidson EP; Dunlap JA; Lund DD; Salvemini D; Yorek MA
    Br J Pharmacol; 2001 Sep; 134(1):21-9. PubMed ID: 11522593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.